Zoom creator loses 4000 plus million euros after the good results of the Pfizer vaccine: The good preliminary results of the vaccine against the coronavirus of the company Pfizer, whose candidate would have managed to immunize 90% of persons who received one dose, according to the company, the company has generated losses to the main winners with the pandemic, such as the company's video conferencing Zoom, after increasing its price by over 500% this year (from $ 70 per title to exceed 400) fell 17% on the day Monday once they met the encouraging data of this candidate vaccine.
On Monday alone, Zoom went from 500 dollars per share (423 euros) to 413 dollars (350 euros) at the close of the market, 17% less, which means an impact of 5.100 million dollars (4.300 million euros) on the assets of its founder Eric Yuan, who has approximately 19% of the company's titles.
Yuan is not the only one who has received the impact of the movement of investors towards companies that can grow in a future post-pandemic scenario, but also other companies that have grown in these months.
The company of equipment for exercising at home Platoon lost 20% on Monday (for $ 125 per share, which closed on Friday at $ 100 on Monday), which represents a discount of us $ 300 million (253 million euros) for its founder, John Foley; or Netflix fell 8% (from 514 euros per title to 470), which resulted in losses of 416 million dollars (351 million euros) to its founder, Reed Hastings. Amazon fell 5% and Shopify 14%.
Manufacturers of sanitary gloves have also fallen, such as the Malaysian company Top Glove Corp, which lost 11%, Riverstone Holdings, 13%, and other companies in the sector such as Hartalega Holdings or Kossan Rubber Industries fell more than 8%.
Zoom creator loses 4000 plus million euros
Other founders who have lost money as a result of the growing expectation of an effective vaccine against the COVID-19 have been Forrest Li, the ceo of the telecommunications company in Singapore Is Group, which on Monday left nearly 1,000 billion dollars (846 million euros) after the fall of its subsidiary, u.s. 9.5%; or the president of the courier company FedEx, Fred Smith, who lost about 250 million dollars (211 million euros) following the decrease of the shares of the company directed by 5.7%.
The immediate impact of the progress in vaccines that could lead to the end of the pandemic in the future have led to a drop solution as a Zoom, but for analysts it is just the "normal volatility" of the markets, as investors seek to buy stocks of companies in sectors affected by the pandemic in anticipation of that can be recovered in the future.
"I don't think the trend around e-commerce, video collaboration platforms or the move to cloud technologies will change because of the impact of the vaccine," says Bloomberg analyst Mandeep Singh.
In Zoom they believe that the position they have acquired in the remote labor market will be consolidated even when the pandemic is already controlled. "Video conferencing has already been integrated into every aspect of our lives," video conferencing company CEO Kelly Steckelberg told Bloomberg TV in June.
Zoom creator loses 4000 plus million euros
Salvador Illa is confident that there will be a "relevant percentage" of the Spanish population vaccinated against the coronavirus by the month of May
After it became known that the vaccine against coronavirus developed by Pfizer and BioNTech Biotechnology has shown in clinical trials a high effectiveness, the Minister of Health, Salvador Illa, has offered an interview on TVE to explain when Spaniards will be able to have access to the vaccine.
Salvador Illa has assured that he hopes that" this week or the next more contracts can be signed with the Pfizer company and other pharmaceuticals " and assures that the first doses will arrive early next year.
The minister added that there is a small chance that they could even arrive before the end of 2020, but he has expressed caution and assured that the most likely scenario is the one that brings the vaccine to 2021.
As for the Pfizer vaccine, Illa has estimated that Spain will receive around "20 million doses", so, being a vaccine that requires a booster dose, 10 million people can be immunized.
The first people to receive them are likely to be Groups at risk and staff most exposed to the virus, and the minister has assured that a working group is examining the criteria that will determine who receives the doses first and will have to assess the suitability of each vaccine for certain groups.
In addition, he has confirmed that "they will be vaccines that will be administered through the National Health System". The exact cost of the doses is unknown, but it would have closed an agreement with the United States that puts the price per dose at 19.50 dollars (about 16.5 euros), according to the Financial Times.
Illa has shown no concern about the specifics of conservation for the vaccine from the pharmaceutical giant, which requires a cooling system that keeps doses a Around 80 degrees below zero.
"The vaccine has Conservation characteristics that make it unique, but the company itself has foreseen this and has provided the logistical means that will make us not have any type of problem in this sense neither in our country nor in any country of the European Union," said Salvador Illa.
His words align with those of Miguel Fernández, CEO of Merck in Spain, who said that "in Spain and in advanced countries in general we have powerful logistics networks to guarantee the cold chain", at the Smart Business Meeting held to address the situation of the pharmaceutical industry.
Given the data that reveal that the Spanish population is increasingly reluctant to get a vaccine against coronavirus when it is available, the minister of Health has assured that the government will continue to work to convey the message that "vaccines save lives".
Illa does not believe that it will be necessary to force vaccination against the coronavirus (a scenario that is yes being raised in Australia) because she has assured that she trusts that "Spanish citizenship will respond very well to a vaccination campaign".
In that line, he has assured that the flu vaccination data-highly recommended this year to avoid co— infections with the coronavirus-reveal that people are getting vaccinated around 30% more than previous years.
"There is an impressive effort between science and industry to ensure that the vaccine is safe and effective," said Salvador Illa, in response to the skepticism.
"The European regulatory framework is very similar to that of the United States and is very strict," he added, emphatically assuring that "people who say vaccines offer doubts lie."
The minister insists on the same message already conveyed by the CEO of Pfizer in Spain, Sergio Rodríguez, during the Smart Business Meeting: "none of the requirements of scientific rigor are being stopped from being met".
"By May we will be able to have a percentage of sufficiently relevant people vaccinated that will allow us to move to a different scenario in the fight against COVID-19," said the minister, without specifying what is that number of vaccinated people he foresees.
Illa's words suggest that he expects the doses of not only Pfizer, but also other pharmaceutical companies that are advanced in their research and with which the European Union has already closed agreements, such as AstraZeneca, to arrive in Spain.
Despite everything, the minister has assured that vaccination will not allow "to take for granted the pandemic completely". It is a warning that many experts have been issuing, who insist that the existence of a vaccine will not allow the restriction measures to relax overnight or eradicate the disease completely.
In this sense, in the short term the minister has indicated that the scenario continues to demand caution and has confirmed that Christmas can not be "the same as last".
Although he has assured that the data reveal a stabilization of cases and has assured that "we will see how we arrive in epidemiological terms to the month of December", the minister has ruled out a scenario of normality in the face of the Christmas holidays.